No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
BRNS Barinthus Biotherapeutics
- 1.100
- +0.040+3.77%
Close Dec 30 16:00 ET
- 1.099
- -0.001-0.13%
Post 20:01 ET
44.25MMarket Cap-0.74P/E (TTM)
1.110High1.040Low30.23KVolume1.050Open1.060Pre Close32.43KTurnover0.11%Turnover RatioLossP/E (Static)40.23MShares4.15952wk High0.28P/B30.28MFloat Cap0.80152wk Low--Dividend TTM27.53MShs Float17.990Historical High--Div YieldTTM6.60%Amplitude0.801Historical Low1.072Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
12 Health Care Stocks Moving In Friday's Pre-Market Session
Barinthus Biotherapeutics Plc (NASDAQ:BRNS) Looks Inexpensive After Falling 35% But Perhaps Not Attractive Enough
Barinthus Biotherapeutics Appoints New Chief Scientific Officer
Press Release: Barinthus Bio Promotes SNAP-TI Co-inventor, Geoffrey Lynn, M.D., Ph.D. to Chief Scientific Officer
European Equities Traded in the US as American Depositary Receipts Rising Monday
Promising Clinical Trials and Potential Functional Cure Drive Buy Rating for Barinthus Biotherapeutics
Heat List
US
Overall
Symbol
Price
% Chg
No Data